Cardiovascular benefits: Wegovy is currently the only GLP-1 treatment licensed in the UK to reduce the risk of major cardiovascular events like heart attacks or strokes in people with obesity and established heart disease
Avoid high-fat and greasy foods, which tend to sit longer in the stomach and amplify nausea when gastric emptying is slowed
The study compares tirzepatide with the long-acting GLP-1 RA, dulaglutide for non-inferiority and superiority, and is currently in progress [61]
De Carli M, Capezzali E, Tonon S, Frossi B
Our dietitian Chantelle can calculate a target based on your weight, goals and medication, so you get individualised advice rather than generic advice
At Elive Health, we take a comprehensive and personalized approach to determine if BPC 157 is right for you